Loucaidou M, Stitchbury J, Lee J, Borrows R, Marshall S E, McLean A G, Cairns T, Griffith M, Hakim N, Palmer A, Papalois V, Welsh K, Taube D
Renal and Transplant Unit, St Mary's Hospital, London, United Kingdom.
Transplant Proc. 2005 May;37(4):1760-1. doi: 10.1016/j.transproceed.2005.03.151.
Acute rejection remains an important cause of graft loss after renal transplantation. It has been suggested that cytokine genotyping may play a predictive role in identifying individuals who are at higher risk of acute rejection with a view to individualizing their immunosuppression. The aim of this study was to investigate any possible associations between acute rejection and certain cytokine polymorphisms.
We genotyped 91 cadaveric renal transplant recipients on tacrolimus-based immunosuppression and 84 of their donors. The cytokine polymorphisms studied were the following: tumor necrosis factor (TNF)-alpha-1032 T/C, TNF-alpha-865 C/A, TNF-alpha-859 G/A, interleukin (IL)1-R1-970 C/T, IL-10 haplotype [-1082, -819, -592], and IL-6-174 C/G.
We found no association between any polymorphism and the incidence of acute rejection. This was true for both the recipient and donor population.
Cytokine polymorphisms did not influence acute rejection in our study. We conclude that in the modern era of immunosuppression cytokine genotyping is not a significant predictor of acute rejection in renal transplantation.
急性排斥反应仍然是肾移植后移植肾丢失的重要原因。有人提出,细胞因子基因分型可能在识别急性排斥反应高风险个体方面发挥预测作用,以便实现免疫抑制的个体化。本研究的目的是调查急性排斥反应与某些细胞因子多态性之间的任何可能关联。
我们对91例接受基于他克莫司免疫抑制治疗的尸体肾移植受者及其84例供者进行了基因分型。所研究的细胞因子多态性如下:肿瘤坏死因子(TNF)-α-1032 T/C、TNF-α-865 C/A、TNF-α-859 G/A、白细胞介素(IL)1-R1-970 C/T、IL-10单倍型[-1082, -819, -592]和IL-6-174 C/G。
我们发现任何多态性与急性排斥反应的发生率之间均无关联。受者和供者群体均是如此。
在我们的研究中,细胞因子多态性并未影响急性排斥反应。我们得出结论,在免疫抑制的现代时代,细胞因子基因分型并非肾移植中急性排斥反应的重要预测指标。